Cabot Reports Q2 GAAP EPS Decline, Announces $79M Restructuring & Plant Closures
summarizeSummary
Cabot Corporation reported a year-over-year decline in Q2 GAAP EPS and announced new, significant restructuring plans involving plant closures in Argentina and the Netherlands, incurring substantial charges.
check_boxKey Events
-
Q2 GAAP EPS Declined Significantly
Diluted GAAP EPS for the quarter ended March 31, 2026, was $1.27, a notable decrease from $1.69 in the prior year's quarter. This contrasts with the adjusted EPS of $1.61 reported in the May 5th 8-K and news, indicating a weaker underlying GAAP performance.
-
New Restructuring Plans Announced
The company committed to a new restructuring plan on May 1, 2026, to cease all operations at its Campana, Argentina plant by year-end 2026 and close multiple manufacturing units at its Botlek, The Netherlands plant over fiscal 2026 and 2027. This provides specific details not fully disclosed in the prior 8-K.
-
Substantial Restructuring Charges Expected
These new restructuring activities are projected to result in approximately $79 million in pre-tax charges to earnings, with $63 million expected in fiscal year 2026 and $16 million in fiscal 2027. Future cash outlays related to these actions are estimated at $24 million.
-
Significant Share Repurchases
Cabot repurchased approximately 649,147 shares of its common stock during the quarter ended March 31, 2026, totaling approximately $48 million. This represents a significant return of capital to shareholders.
auto_awesomeAnalysis
This 10-Q filing reveals a significant year-over-year decline in GAAP earnings per share, which contrasts with the adjusted EPS beat reported in recent news and an 8-K filing. This divergence could signal underlying profitability challenges. The company also disclosed new, substantial restructuring plans, including the cessation of operations at its Campana, Argentina plant and the closure of multiple manufacturing units in Botlek, The Netherlands. These actions are expected to result in $79 million in pre-tax charges and $24 million in future cash outlays, indicating a strategic shift to address market conditions and optimize its manufacturing network. While the company continued its share repurchase program, the magnitude of the GAAP earnings decline and the new restructuring initiatives present a negative outlook for investors, suggesting operational headwinds despite efforts to return capital.
At the time of this filing, CBT was trading at $82.41 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $58.33 to $85.27. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.